Devex: The many challenges of tackling substandard and falsified medicines
“…The scale of the distribution of [substandard and falsified medicines] — which range from drugs that fail to meet quality standards to medical products that deliberately misrepresent what they are — is only beginning to emerge, although WHO puts the rate at 1 out of every 10 medicines in lower-income countries. That didn’t stop experts at the World Health Summit, which launched in Berlin on Sunday, from using the meeting to discuss some of the legislative and technological approaches to stopping their procurement and distribution…” (Green, 10/29).